Lista de obras - Jonathan K Ball - Dominio Público Uruguay

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.

artículo científico publicado en 2015

A case of hepatitis C virus transmission acquired through sharing a haemodialysis machine.

artículo científico publicado en 2010

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

artículo científico publicado en 2017

A polymerase chain reaction method for the amplification of full-length envelope genes of HIV-1 from DNA samples containing single molecules of HIV-1 provirus

artículo científico publicado en 2000

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

artículo científico publicado en 2013

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule

artículo científico publicado en 2015

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

artículo científico publicado en 2014

Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets

artículo científico publicado en 2005

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.

artículo científico publicado en 2008

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins

artículo científico publicado en 2014

Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin

artículo científico publicado en 2016

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

artículo científico publicado en 2007

Challenges on the development of a pseudotyping assay for Zika glycoproteins

artículo científico publicado en 2021

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

artículo científico publicado en 2005

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

artículo científico publicado en 2006

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin

artículo científico publicado en 2015

Concordance between semen-derived HIV-1 proviral DNA and viral RNA hypervariable region 3 (V3) envelope sequences in cases where semen populations are distinct from those present in blood

artículo científico publicado en 2002

Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy.

artículo científico publicado en 1996

Coronavirus (CoV) proteins in GtoPdb v.2022.2

artículo científico publicado en 2022

Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes

artículo científico publicado en 2007

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

artículo científico publicado en 2008

Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8

artículo científico publicado en 1998

Detection of HIV-1 by digoxigenin-labelled PCR and microtitre plate solution hybridisation assay and prevention of PCR carry-over by uracil-N-glycosylase

scientific article published on 01 September 1993

Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.

artículo científico publicado en 2007

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

artículo científico publicado en 2017

Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region.

artículo científico publicado en 2014

Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA.

artículo científico publicado en 2001

Discovery of Novel Alphacoronaviruses in European Rodents and Shrews

artículo científico publicado en 2016

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation

artículo científico publicado en 2014

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.

artículo científico publicado en 2005

Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity

artículo científico publicado en 2002

Flexible and rapid construction of viral chimeras applied to hepatitis C virus.

artículo científico publicado en 2016

Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.

artículo científico publicado en 1994

HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix.

artículo científico publicado en 2005

HIV-1 co-receptor expression and epithelial immune cells of the cervix in asymptomatic women attending a genitourinary medicine clinic.

artículo científico publicado en 2012

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

artículo científico publicado en 2009

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

artículo científico publicado en 2011

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host

artículo científico publicado en 2012

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals

artículo científico publicado en 2016

Human Adaptation of Ebola Virus during the West African Outbreak

artículo científico publicado en 2016

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

artículo científico publicado en 2007

Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes

artículo científico publicado en 2022

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

artículo científico publicado en 2006

Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2

artículo científico publicado en 2011

Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors

artículo científico publicado en 2011

Long-lasting viability of HIV after patient's death.

artículo científico publicado en 1991

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

artículo científico publicado en 2005

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

artículo científico publicado en 2012

Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step

artículo científico publicado en 2011

Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces.

artículo científico publicado en 2015

Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

artículo científico publicado en 2006

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.

artículo científico publicado en 2016

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

artículo científico publicado en 2015

Polymer microarrays rapidly identify competitive adsorbents of virus-like particles

artículo científico publicado en 2020

Production of Single-Stranded DNA Using a Uracil-N-glycosylase-Mediated Asymmetric Polymerase Chain Reaction Method ⬇️

artículo científico publicado el 15 de noviembre de 1997

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

artículo científico publicado en 2014

SARS-CoV-2 proteins (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database

scientific article published on 12 May 2020

Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex

artículo científico publicado en 2007

Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.

artículo científico publicado en 2010

Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.

artículo científico publicado en 2014

TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types.

artículo científico publicado en 1999

Tagged polymerase chain reaction subtractive hybridization for the enrichment of phage display random peptide libraries.

artículo científico publicado en 2005

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

artículo científico publicado en 2015

The past, present and future of neutralizing antibodies for hepatitis C virus

artículo científico publicado en 2014

The role of humoral innate immunity in hepatitis C virus infection.

artículo científico

The role of neutralizing antibodies in hepatitis C virus infection.

artículo científico publicado en 2011

The use of uracil-N-glycosylase in the preparation of PCR products for direct sequencing.

artículo científico publicado en 1992

Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies

artículo científico publicado en 2013

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

artículo científico publicado en 2008

Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis

artículo científico publicado en 2010

Lista de obras de Jonathan K Ball

A Diverse Panel of Hepatitis C Virus Glycoproteins for Use in Vaccine Research Reveals Extremes of Monoclonal Antibody Neutralization Resistance.

A case of hepatitis C virus transmission acquired through sharing a haemodialysis machine.

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

A polymerase chain reaction method for the amplification of full-length envelope genes of HIV-1 from DNA samples containing single molecules of HIV-1 provirus

An alpaca nanobody inhibits hepatitis C virus entry and cell-to-cell transmission

An ancestral host defence peptide within human β-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule

Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution

Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets

Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.

B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins

Broad neutralization of hepatitis C virus-resistant variants by Civacir hepatitis C immunoglobulin

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Challenges on the development of a pseudotyping assay for Zika glycoproteins

Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin

Concordance between semen-derived HIV-1 proviral DNA and viral RNA hypervariable region 3 (V3) envelope sequences in cases where semen populations are distinct from those present in blood

Concurrent evolution of regions of the envelope and polymerase genes of human immunodeficiency virus type 1 during zidovudine (AZT) therapy.

Coronavirus (CoV) proteins in GtoPdb v.2022.2

Cross-genotype characterization of genetic diversity and molecular adaptation in hepatitis C virus envelope glycoprotein genes

Definition of a Conserved Immunodominant Domain on Hepatitis C Virus E2 Glycoprotein by Neutralizing Human Monoclonal Antibodies

Dendritic cells cultured from mononuclear cells and CD34 cells in myeloma do not harbour human herpesvirus 8

Detection of HIV-1 by digoxigenin-labelled PCR and microtitre plate solution hybridisation assay and prevention of PCR carry-over by uracil-N-glycosylase

Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region.

Development of a strand-specific RT-PCR based assay to detect the replicative form of hepatitis C virus RNA.

Discovery of Novel Alphacoronaviruses in European Rodents and Shrews

Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation

Evolutionary dynamics of hepatitis C virus envelope genes during chronic infection.

Evolutionary trends of the first hypervariable region of the hepatitis C virus E2 protein in individuals with differing liver disease severity

Flexible and rapid construction of viral chimeras applied to hepatitis C virus.

Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy.

HIV coreceptor and chemokine ligand gene expression in the male urethra and female cervix.

HIV-1 co-receptor expression and epithelial immune cells of the cervix in asymptomatic women attending a genitourinary medicine clinic.

Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes

Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.

Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host

Hepatitis C virus quasispecies and pseudotype analysis from acute infection to chronicity in HIV-1 co-infected individuals

Human Adaptation of Ebola Virus during the West African Outbreak

Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus

Human parainfluenza 2 & 4: Clinical and genetic epidemiology in the UK, 2013–2017, reveals distinct disease features and co‐circulating genomic subtypes

Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding

Identification of New Functional Regions in Hepatitis C Virus Envelope Glycoprotein E2

Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors

Long-lasting viability of HIV after patient's death.

Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein

Naturally occurring antibodies that recognize linear epitopes in the amino terminus of the hepatitis C virus E2 protein confer noninterfering, additive neutralization

Neutralizing monoclonal antibodies against hepatitis C virus E2 protein bind discontinuous epitopes and inhibit infection at a postattachment step

Non-ionic detergents facilitate non-specific binding of M13 bacteriophage to polystyrene surfaces.

Non-macrophage-tropic human immunodeficiency virus type 1 R5 envelopes predominate in blood, lymph nodes, and semen: implications for transmission and pathogenesis.

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

Polymer microarrays rapidly identify competitive adsorbents of virus-like particles

Production of Single-Stranded DNA Using a Uracil-N-glycosylase-Mediated Asymmetric Polymerase Chain Reaction Method ⬇️

Recombinant human L-ficolin directly neutralizes hepatitis C virus entry.

SARS-CoV-2 proteins (version 2020.2) in the IUPHAR/BPS Guide to Pharmacology Database

Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex

Specific interaction of hepatitis C virus glycoproteins with mannan binding lectin inhibits virus entry.

Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.

TT virus sequence heterogeneity in vivo: evidence for co-infection with multiple genetic types.

Tagged polymerase chain reaction subtractive hybridization for the enrichment of phage display random peptide libraries.

Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice

The past, present and future of neutralizing antibodies for hepatitis C virus

The role of humoral innate immunity in hepatitis C virus infection.

The role of neutralizing antibodies in hepatitis C virus infection.

The use of uracil-N-glycosylase in the preparation of PCR products for direct sequencing.

Use of short tandem repeat fingerprinting to validate sample origins in hepatitis C virus molecular epidemiology studies

Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors.

Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis